PGR and breast carcinoma: One of the limitations of our study was that we didn’t evaluate survival and recurrence status in these two subtypes of her2neu positive breast cancers and therefore we suggest that more prospective studies should be done to evaluate if there is any survival benefit of ER/PR positivity in her2neu positive breast cancers.